These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 17210704)
1. Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathways. Vijapurkar U; Wang W; Herbst R Cancer Res; 2007 Jan; 67(1):237-45. PubMed ID: 17210704 [TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint. Chin GM; Herbst R Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103 [TBL] [Abstract][Full Text] [Related]
3. Induction of apoptosis by an inhibitor of the mitotic kinesin KSP requires both activation of the spindle assembly checkpoint and mitotic slippage. Tao W; South VJ; Zhang Y; Davide JP; Farrell L; Kohl NE; Sepp-Lorenzino L; Lobell RB Cancer Cell; 2005 Jul; 8(1):49-59. PubMed ID: 16023598 [TBL] [Abstract][Full Text] [Related]
4. Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition. Luo L; Carson JD; Dhanak D; Jackson JR; Huang PS; Lee Y; Sakowicz R; Copeland RA Biochemistry; 2004 Dec; 43(48):15258-66. PubMed ID: 15568818 [TBL] [Abstract][Full Text] [Related]
5. Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol. Asraf H; Avunie-Masala R; Hershfinkel M; Gheber L PLoS One; 2015; 10(6):e0129255. PubMed ID: 26035434 [TBL] [Abstract][Full Text] [Related]
6. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5. Kapoor TM; Mayer TU; Coughlin ML; Mitchison TJ J Cell Biol; 2000 Sep; 150(5):975-88. PubMed ID: 10973989 [TBL] [Abstract][Full Text] [Related]
7. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5. DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161 [TBL] [Abstract][Full Text] [Related]
8. Mcl-1 stability determines mitotic cell fate of human multiple myeloma tumor cells treated with the kinesin spindle protein inhibitor ARRY-520. Tunquist BJ; Woessner RD; Walker DH Mol Cancer Ther; 2010 Jul; 9(7):2046-56. PubMed ID: 20571074 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of a mitotic motor protein: where, how, and conformational consequences. Yan Y; Sardana V; Xu B; Homnick C; Halczenko W; Buser CA; Schaber M; Hartman GD; Huber HE; Kuo LC J Mol Biol; 2004 Jan; 335(2):547-54. PubMed ID: 14672662 [TBL] [Abstract][Full Text] [Related]
10. A novel bis-benzylidenecyclopentanone derivative, BPR0Y007, inducing a rapid caspase activation involving upregulation of Fas (CD95/APO-1) and wild-type p53 in human oral epidermoid carcinoma cells. Juang SH; Pan WY; Kuo CC; Liou JP; Hung YM; Chen LT; Hsieh HP; Chang JY Biochem Pharmacol; 2004 Jul; 68(2):293-303. PubMed ID: 15194001 [TBL] [Abstract][Full Text] [Related]
11. Kinesin spindle protein (KSP) inhibitors. Part 1: The discovery of 3,5-diaryl-4,5-dihydropyrazoles as potent and selective inhibitors of the mitotic kinesin KSP. Cox CD; Breslin MJ; Mariano BJ; Coleman PJ; Buser CA; Walsh ES; Hamilton K; Huber HE; Kohl NE; Torrent M; Yan Y; Kuo LC; Hartman GD Bioorg Med Chem Lett; 2005 Apr; 15(8):2041-5. PubMed ID: 15808464 [TBL] [Abstract][Full Text] [Related]
12. Bis(hetero)aryl derivatives as unique kinesin spindle protein inhibitors. Matsuno K; Sawada J; Sugimoto M; Ogo N; Asai A Bioorg Med Chem Lett; 2009 Feb; 19(4):1058-61. PubMed ID: 19167222 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of Eg5 acts synergistically with checkpoint abrogation in promoting mitotic catastrophe. Chen Y; Chow JP; Poon RY Mol Cancer Res; 2012 May; 10(5):626-35. PubMed ID: 22522457 [TBL] [Abstract][Full Text] [Related]
14. An inhibitor of the kinesin spindle protein activates the intrinsic apoptotic pathway independently of p53 and de novo protein synthesis. Tao W; South VJ; Diehl RE; Davide JP; Sepp-Lorenzino L; Fraley ME; Arrington KL; Lobell RB Mol Cell Biol; 2007 Jan; 27(2):689-98. PubMed ID: 17101792 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of KSP by ARRY-520 induces cell cycle block and cell death via the mitochondrial pathway in AML cells. Carter BZ; Mak DH; Woessner R; Gross S; Schober WD; Estrov Z; Kantarjian H; Andreeff M Leukemia; 2009 Oct; 23(10):1755-62. PubMed ID: 19458629 [TBL] [Abstract][Full Text] [Related]
16. Discovery of novel spiro 1,3,4-thiadiazolines as potent, orally bioavailable and brain penetrant KSP inhibitors. Mansoor UF; Angeles AR; Dai C; Yang L; Vitharana D; Basso AD; Gray K; Tang H; Liu M; Liang L; Allbritton O; Siddiqui MA Bioorg Med Chem; 2015 May; 23(10):2424-34. PubMed ID: 25868746 [TBL] [Abstract][Full Text] [Related]
17. Proteome analysis of apoptosis signaling by S-trityl-L-cysteine, a potent reversible inhibitor of human mitotic kinesin Eg5. Kozielski F; Skoufias DA; Indorato RL; Saoudi Y; Jungblut PR; Hustoft HK; Strozynski M; Thiede B Proteomics; 2008 Jan; 8(2):289-300. PubMed ID: 18186019 [TBL] [Abstract][Full Text] [Related]
18. Helenalin triggers a CD95 death receptor-independent apoptosis that is not affected by overexpression of Bcl-x(L) or Bcl-2. Dirsch VM; Stuppner H; Vollmar AM Cancer Res; 2001 Aug; 61(15):5817-23. PubMed ID: 11479221 [TBL] [Abstract][Full Text] [Related]